http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013213661-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4410553fa514ec20fab08e96db05580 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
| filingDate | 2013-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b535b076de774d3020705c73df5e48fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b6504c599033f3f474589ab6c888c44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac2ff5e3e30cab7c06e50d231dce9b2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92fc266df87409efb48ef450f240f227 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3581ea56cc4d705765f420667434334f |
| publicationDate | 2013-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2013213661-A1 |
| titleOfInvention | Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs |
| abstract | The present invention relates to the use and methods of producing an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the treatment of several clinical manifestations associated with a porcine circovirus infection in pigs. Preferably, the manifestations include lymphadenopathy, lymphoid depletion and/or multinucleated or giant histiocytes which may furthermore be included with symptoms such as (1) interstitial pneumonia with interlobular edema, (2) cutaneous pallor or icterus, (3) mottled atrophic livers, (4) gastric ulcers, (5) nephritis (6) pia like lesions, and/or (7) reproductive disorders. |
| priorityDate | 2005-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 145.